Hemodialysis. Chronic kidney disease, stage 5, End stage kidney disease: on dialysis
Conditions
Interventions
Intervention 1: Intervention group: 50 gramme of fortified dessert per day for 2 months. Intervention 2: Control group: 50 gramme of placebo dessert for 2 months.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients who are on dialysis more than 6 months Patients with KT/V > 1.2 Patients who are vigilant and can-do Who are on special regiment for dialysis patients Patients who did not have any changes in their recieved erythropoitin for a month
Exclusion criteria
Exclusion criteria: Patients with diabetes, cancer, malignity and autoimmune diseases Patients who are sensitive to dairy products Patients who are grafted and grafted kidney is in their body Patients with vitamin D level more than 70
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malondialdehyde (MDA). Timepoint: Before and 60 days after intervention. Method of measurement: Spectrophotometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Malnutrition-inflammation score. Timepoint: Before and 60 days after intervention. Method of measurement: Questionnaire.;Subjective global assessment. Timepoint: Before and 60 days after intervention. Method of measurement: Questionnaire.;Quality of life. Timepoint: Before and 60 days after intervention. Method of measurement: Questionnaire.;Vitamin D. Timepoint: Before and 60 days after intervention. Method of measurement: ELISA.;Total antioxidant capacity. Timepoint: Before and 60 days after intervention. Method of measurement: ELISA.;HsCRP. Timepoint: Before and 60 days after intervention. Method of measurement: ELISA.;CBC. Timepoint: Before and 60 days after intervention. Method of measurement: Cell counter.;Sodium. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Potasium. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Phosphor. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Calcium. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Albumin. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Cratinine. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Urea. Timepoint: Before and 60 days after intervention. Method of measurement: Autoanalyser.;Ferritin. Timepoint: Before and 60 days after intervention. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Ekramzade
Shiraz University of Medical Sciences
Outcome results
None listed